You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 23, 2024

Claims for Patent: 7,718,783

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 7,718,783

Title:	ELF3 gene compositions and methods
Abstract:	ELF3 gene compositions associated with cancer are provided, including ELF3 mRNA intron retention, a novel ELF3 5\' untranslated region, and a novel Alu, Alu.sub.kwd. Methods and kits using primers or probes to detect the presence of these ELF3 gene compositions are also provided. Methods for determining whether a cell comprises a virus are also provided.
Inventor(s):	Kaplan; Mark H. (Ann Arbor, MI), Dosik; Michael H. (East Setauket, NY), Wang; Xue-Ping (Port Washington, NY)
Assignee:
Application Number:	10/535,378
Patent Claims:	1. An isolated cDNA molecule of a mammalian ELF3 gene, wherein said cDNA molecule consists of an ELF3 cDNA sequence and one or more of intron 4, intron 5, intron 6, intron 7 and intron 8 of the ELF3 gene, wherein the ELF3 gene consists of a contiguous sequence set forth in SEQ ID NO:10. 2. The cDNA molecule of claim 1, wherein the intron is selected from the group consisting of intron 4, intron 5, intron 6 and intron 7. 3. The cDNA molecule of claim 1, comprising SEQ ID NO:11. 4. The cDNA molecule of claim 1, wherein the cDNA molecule comprises the nucleotide sequence of SEQ ID NO:15.

Details for Patent 7,718,783

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986	⤷ Try a Trial	2022-11-22
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132		⤷ Try a Trial	2022-11-22
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132		⤷ Try a Trial	2022-11-22
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.